HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Roles of the hexosamine biosynthetic pathway and pentose phosphate pathway in bile acid-induced cancer development.

Abstract
Esophageal squamous cell carcinomas (ESCCs) as well as adenocarcinomas (EACs) were developed in rat duodenal contents reflux models (reflux model). The present study aimed to shed light on the mechanism by which bile acid stimulation causes cancer onset and progression. Metabolomics analyses were performed on samples of neoplastic and nonneoplastic tissues from reflux models, and K14D, cultivated from a nonmetastatic, primary ESCC, and ESCC-DR, established from a metastatic thoracic lesion. ESCC-DRtca2M was prepared by treating ESCC-DR cells with taurocholic acid (TCA) to accelerate cancer progression. The lines were subjected to comprehensive genomic analyses. In addition, protein expression levels of glucose-6-phosphate dehydrogenase (G6PD), nuclear factor kappa B (NF-κB) (p65) and O-linked N-Acetylglucosamine (O-GlcNAc) were compared among lines. Cancers developed in the reflux models exhibited greater hexosamine biosynthesis pathway (HBP) activation compared with the nonneoplastic tissues. Expression of O-GlcNAc transferase (OGT) increased considerably in both ESCC and EAC compared with nonneoplastic squamous epithelium. Conversely, cell line-based experiments revealed the greater activation of the pentose phosphate pathway (PPP) at higher degrees of malignancy. G6PD overexpression in response to TCA exposure was observed. Both NF-κB (p65) and O-GlcNAc were expressed more highly in ESCC-DRtca2M than in the other cell lines. Moreover, ESCC-DRtca2M cells had additional chromosomal abnormalities in excess of ESCC-DR cells. Overall, glucose metabolism was upregulated in both esophageal cancer tissue and cell lines. While bile acids are not mutagenic, chronic exposure seems to trigger NF-κB(p65) activation, potentially inducing genetic mutations as well as facilitating carcinogenesis and cancer progression. Glucose metabolism was upregulated in both esophageal cancer tissue and cell lines, and the HBP was activated in the former. The cell line-based experiments demonstrated upregulation of the pentose phosphate pathway (PPP) at higher degrees of malignancy. While bile acids are not mutagenic, chronic exposure seems to trigger G6PD overexpression and NF-κB (p65) activation, potentially inducing genetic mutations as well as facilitating carcinogenesis and cancer progression.
AuthorsMasayoshi Munemoto, Ken-Ichi Mukaisho, Tomoharu Miyashita, Katsunobu Oyama, Yusuke Haba, Koichi Okamoto, Jun Kinoshita, Itasu Ninomiya, Sachio Fushida, Naoko Taniura, Hiroyuki Sugihara, Takashi Fujimura
JournalCancer science (Cancer Sci) Vol. 110 Issue 8 Pg. 2408-2420 (Aug 2019) ISSN: 1349-7006 [Electronic] England
PMID31215094 (Publication Type: Journal Article)
Copyright© 2019 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
Chemical References
  • 2-epsilon-lysino-2-deoxy-6-phosphoglucose
  • Bile Acids and Salts
  • Hexosamines
  • NF-kappa B
  • Glucosephosphate Dehydrogenase
  • Glucose
  • Lysine
  • Acetylglucosamine
Topics
  • Acetylglucosamine (metabolism)
  • Adenocarcinoma (metabolism, pathology)
  • Animals
  • Bile Acids and Salts (metabolism)
  • Biosynthetic Pathways (physiology)
  • Cell Line, Tumor
  • Esophageal Neoplasms (metabolism, pathology)
  • Esophageal Squamous Cell Carcinoma (metabolism, pathology)
  • Gene Expression Regulation, Neoplastic (physiology)
  • Glucose (analogs & derivatives, metabolism)
  • Glucosephosphate Dehydrogenase (metabolism)
  • Hexosamines (metabolism)
  • Lysine (analogs & derivatives, metabolism)
  • Male
  • NF-kappa B (metabolism)
  • Pentose Phosphate Pathway (physiology)
  • Rats
  • Rats, Wistar
  • Signal Transduction (physiology)
  • Up-Regulation (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: